Lab-on-a-Chip and Microfluidics World Congress 2026: POC-Rapid Dx + Organs-on-Chips
Date: Tuesday, October 27, 2026 - Wednesday, October 28, 2026
Location: VOCO Hotel -- Laguna Hills, California
Confirmed Speakers
Abraham Lee, Professor, Ctr for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine
Claudia Gärtner, CEO, microfluidic ChipShop GmbH
Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz
Noah Malmstadt, Professor, Mork Family Dept. of Chemical Engineering & Materials Science, University of Southern California
Xing Wang, Associate Professor, Holonyak Micro and Nanotechnology Laboratory (HMNTL) Cancer Center at Illinois (CCIL), University of Illinois at Urbana-Champaign (UIUC)
Abraham Qavi, Assistant Professor, Director of Point of Care Testing, Director of Innovative Laboratory Diagnostics, University of California-Irvine
Greg Cooksey, Project Leader, Microsystems and Nanotechnology Division, National Institute of Standards and Technology (NIST)
Min-Gon Kim, Professor at GIST (Gwangju Institute of Science and Technology), CEO of GMDBiotech
Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering
Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign
Gregory Nordin, Professor, Brigham Young University - Plenary Speaker
Nancy Allbritton, Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington - Plenary Speaker
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas - Plenary Speaker
Overview of the Conference
SelectBIO Lab-on-a-Chip and Microfluidics World Congress 2026: POC-Rapid Dx + Organs-on-Chips takes place October 27-28, 2026 at the VOCO Hotel, Laguna Hills, California, USA.
This conference brings together academic researchers, industry scientists, and companies from the US, Europe and Asia/Pacific in a focused 2-day event featuring academic presentations on cutting-edge science, company presentations, technology/tools vendor presentations and instrumentation demos plus exhibitors and networking opportunities.
The conference welcomes doctoral students, post-doctoral and research fellows to submit abstracts for oral presentations on their research as it relates to the goals of this conference -- featuring the latest research, engaging researchers and companies, and extensive networking and collaboration opportunities.
**Co-located and Held Concurrently with the Extracellular Vesicles (EVs)-Lipid Nanoparticles (LNPs) -- Each Registration Provides Full Access to Both Tracks, Workshops and All Networking Events**
Abstract Submission for Oral and Poster Presentations
Agenda Topics Covered at this Conference
You can present your research in an oral presentation or poster while attending the meeting. Submit an abstract for consideration under the Submissions tab of this conference website
Oral Presentation Abstract Submission Deadline: August 31, 2026
Poster Presentation Abstract Submission Deadline: October 16, 2026
3D-Printing and its Convergence with the Microfluidics/Lab-on-a-Chip Marketplace
3D-Printing, Biofabrication and Bioprinting using Microfluidics
Biosensors
Digital Microfluidics
Lab-on-a-Chip and Microfluidics for Point-of-Care Diagnostic Testing and Global Health Applications
Microfluidic/LOAC Device Manufacturing: Technologies and Companies Showcase
Microfluidics and Lab-on-a-Chip: Life Science Research Applications
Microfluidics Tools for Single Cell Analysis
New Entrants from Around the World Expand the Market Opportunities for Microfluidics and Lab-on-a-Chip
Organoids and Organs-on-Chips
Point-of-Care and Rapid Diagnostics
Rare Cell Capture & Circulating Biomarkers Studied Using Microfluidics
Sponsorship and Exhibition Opportunities
3-for-2 Offer on Delegate Registrations
SelectBIO are offering 3 Delegate Registrations for the price of 2 on all delegate passes. To take advantage of this offer, please contact us by email, phone or click the Contact Us button below. Looking for more than 3 Delegate Passes? Contact us for more information on our special rates for large groups.
Any questions or assistance during registration, please call us at: +1 (510) 857-4865 or e-mail us at: Contact SelectBIO
Gold Sponsors
Exhibitors
Sponsorship and Exhibition Opportunities
If you require any information about exhibiting or sponsoring at one of our events please contact Jeff Fan using the information below:
Jeff Fan
Exhibition Manager - SelectBIO Conferences
Why Sponsor-Exhibit at a SelectBIO Conference?
Specialists: SelectBIO doesn't organize conferences in shipping, accountancy, textiles etc. – just life sciences. Many of our staff have bioscience qualifications and many years of experience. So, we speak your language and understand your needs.
Superior Customer Service: Our sales team will take care of you with specialist advice and customized packages.
We don’t forget you after you sign on the bottom line either as our customer service dept. will alert you to all the things you need to think about up to and during the event itself.
Lab-on-a-Chip and Microfluidics World Congress 2026 Conference Venue
SelectBIO is pleased to host Lab-on-a-Chip and Microfluidics World Congress 2026 Conference at VOCO Laguna Hills: An IHG Hotel -- Laguna Hills, California.
VOCO Laguna Hills
25205 La Paz Road
Laguna Hills, California 92653, USA
Telephone: (949) 586-5000
This hotel in Southern California is easily accessible from Los Angeles and San Diego via Interstate-5 (I-5).
The nearest airport is: John Wayne Airport (SNA) - 13.7 miles from the hotel.
From Los Angeles International Airport (LAX) - the hotel is 52.9 miles.
The hotel is within a short drive of Disneyland and Legoland California, as well as Laguna Beach, Newport Beach, as well as shopping and dining at South Coast Plaza in Costa Mesa.
All conference sessions, exhibition as well as networking reception will be held in the Crystal Ballroom at VOCO Laguna Hills.
SelectBIO has negotiated discounted hotel room pricing for conference attendees at VOCO Laguna Hills.
To make your Hotel Reservations Online: Click the Button Below to Open the Hotel Booking Website. This will provide a SelectBIO discounted rate for booking hotel rooms.
For any questions with the venue or logistics matters, please kindly contact SelectBIO Conferenes:
Jeff Fan
Events Manager, SelectBIO Conferences
E-mail: Jeff@selectbioconferences.com
SelectBIO has NOT authorized ANY third party company to assist in hotel bookings or any bookings or reservations for this conference. Please do NOT do business with any third party companies. If in doubt, please contact Jeff Fan immediately to clarify.
Register to this conference and also enjoy the following co-located events at no extra charge.
Training Courses
If you would like to submit a proposal for an oral or poster presentation at this meeting, please fill out the form below required for your submission.
Successful applicants will be provided with all necessary information.
Abstract Content:
-
Written in English
-
Written in the third person
-
Include title, name(s) and affiliation(s) of the authors
-
Between 100 - 200 words
-
Suitable for direct publication in the proceedings pack and on the website
-
Related to the subject of the conference
Agenda Topics
3D-Printing and its Convergence with the Microfluidics/Lab-on-a-Chip Marketplace
3D-Printing, Biofabrication and Bioprinting using Microfluidics
Biosensors
Digital Microfluidics
Lab-on-a-Chip and Microfluidics for Point-of-Care Diagnostic Testing and Global Health Applications
Microfluidic/LOAC Device Manufacturing: Technologies and Companies Showcase
Microfluidics and Lab-on-a-Chip: Life Science Research Applications
Microfluidics Tools for Single Cell Analysis
New Entrants from Around the World Expand the Market Opportunities for Microfluidics and Lab-on-a-Chip
Organoids and Organs-on-Chips
Point-of-Care and Rapid Diagnostics
Rare Cell Capture & Circulating Biomarkers Studied Using Microfluidics
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.
Abraham Lee, Professor, Biomedical & Mechanical Engineering, Pharmaceutical Science, Ctr for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine
Abe Lee Biographical Sketch
Abraham (Abe) P. Lee is Chancellor’s Professor of Biomedical Engineering (BME) and MAE at the University of California, Irvine (UCI). He served as department chair for BME from 2010-2019. He is currently Director of the NSF I/UCRC “Center for Advanced Design & Manufacturing of Integrated Microfluidics” (CADMIM). Dr. Lee served as Editor-in-Chief for the Lab on a Chip journal from 2017-2020. Prior to UCI, he was Senior Technology Advisor at National Cancer Institute (NCI), Program Manager in the Microsystems Technology Office at DARPA (1999-2001), and a group leader with Lawrence Livermore National Lab (LLNL). Dr. Lee’s current research focuses on integrated microfluidic systems for precision medicine including liquid biopsy, microphysiological systems, cell engineering, and immunotherapy. His research has contributed to the founding of several start-up companies. He is inventor of over 60 issued US patents and is author of over 130 journals articles. Professor Lee was awarded the 2009 Pioneers of Miniaturization Prize and is fellow of the National Academy of Inventors (NAI), the American Institute of Medical and Biological Engineering (AIMBE), the Royal Society of Chemistry (RSC), the American Society of Mechanical Engineering (ASME), the International Academy of Medical and Biological Engineering, and the Biomedical Engineering Society (BMES).
Abraham Qavi, Assistant Professor, Director of Point of Care Testing, Director of Innovative Laboratory Diagnostics, University of California-Irvine
Abraham Qavi Biographical Sketch
Abraham Qavi is a physician-scientist and faculty member in the Department of Pathology and Laboratory Medicine at the University of California, Irvine. His expertise focuses on point-of-care diagnostics, biosensing technologies, and clinical laboratory stewardship. Dr. Qavi’s work bridges fundamental sensor development with translational and operational considerations in hospital-based laboratories, emphasizing technologies that can meaningfully impact patient care.
Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign
Brian Cunningham Biographical Sketch
Professor Cunningham has been a faculty member in the department of Electrical and Computer Engineering and the department Bioengineering at the University of Illinois at Urbana-Champaign since 2004, following a 15-year career in Industry. Prof. Cunningham’s technical focus is the utilization of photonics for biosensing in applications that include life science research, diagnostics, environmental monitoring, and pharmaceutical screening. He has over 90 issued US patents and over 200 peer reviewed journal publications. He is a Fellow of NAI, IEEE, Optica, RSC, AAAS, and AIMBE. He serves as the Director of the Center for Genomic Diagnostics at the Woese Institute for Genomic Biology, and as a Program Leader for the Cancer Center at Illinois on the topic of Cancer Measurement Technology and Data Science. In 2023, his technical contributions were recognized by Optica by the Michael S. Feld Biophotonics Award.
Claudia Gärtner, CEO, microfluidic ChipShop GmbH
Claudia Gärtner Biographical Sketch
Claudia Gärtner, PhD, studied chemistry and biology at the university of Duesseldorf, Germany. She obtained her PhD in biochemistry and became involved with microtechnologies at the Institute of Microtechnology Mainz (IMM). In 1999 Dr. Gärtner took over the position of the director of the newly founded Application Center for Microtechnology Jena, Germany (amt) where she built up the technological infrastructure for the realization of miniaturized systems and established Lab-on-a-Chip technology. In 2002 she founded “microfluidic ChipShop” focusing on miniaturized analytical systems and the fabrication of microsystems and was named CEO in 2006. She built up the company from the starting point to a team of roughly 115 employees in the microfluidic ChipShop group.
Dr. Gärtner is member of the advisory board of the Trade Fair Erfurt, the Fraunhofer project center MEOS, the Max Planck Institute for Chemical Ecology and member of the board of trustees of the German Museum in Munich.
Greg Cooksey, Project Leader, Microsystems and Nanotechnology Division, National Institute of Standards and Technology (NIST)
Greg Cooksey Biographical Sketch
Dr. Cooksey is a Project Leader in the Microsystems and Nanotechnology Division at the National Institute of Standards and Technology (NIST). His lab develops microfluidic platforms with integrated optical structures to measure fluids, particles, and cells with high precision. His team’s optofluidic flow meter is the most accurate flow metrology platform in the world, and it has a response time on the order of 0.1 s at 1 nL/min. Dr. Cooksey also leads a microfluidic cytometry project that uses multiple interrogation regions to extract first ever per-object uncertainty quantification and measurement of dynamics in flow. This technology was awarded a Gold Medal and the 2023 Ron Brown Excellence in Innovation Award by the U.S. Department of Commerce.
Gregory Nordin, Professor, Brigham Young University
Gregory Nordin Biographical Sketch
Professor Greg Nordin joined the faculty of the Electrical & Computer Engineering Department at Brigham Young University in 2005. From 1992 to 2005 he was at The University of Alabama in Huntsville (UAH) where he was the founding director of the university's Nano and Micro Devices Center, which was created as an independent research center by the University of Alabama System Board of Trustees. While director of the center, he created a 7,600 sq. ft. cleanroom facility for nano and microfabricated devices to pursue research activities in photonics, MEMS, microfluidics, and sensors. Prof. Nordin has led numerous large research programs, and has been principal investigator on research grants from government and industry totaling $18M. He is the recipient of the National Science Foundation CAREER award (1996) for promising young faculty, and twice received the UAH Outstanding Researcher Award as well as the UAH Foundation Award for Research and Creative Achievement. Prof. Nordin's current research is focused on developing 3D printing for microfluidic devices and applications. In March 2018 Prof. Nordin gave a TED talk on his group's work, which is available at https://www.youtube.com/watch?v=T122fzOEVYE.
Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz
Holger Schmidt Biographical Sketch
Holger Schmidt received the Ph.D. degree in electrical and computer engineering from the University of California Santa Barbara and served as a Postdoctoral Fellow at M.I.T. He is currently the Narinder Kapany Chair of Optoelectronics and Distinguished Professor of Electrical and Computer Engineering at UC Santa Cruz. He directs the W.M. Keck Center for Nanoscale Optofluidics and has served as the Associate Dean for Research in the Baskin School of Engineering. His research interests cover a broad range in photonics and integrated optics, including optofluidic devices, nanopore sensors, nano-magneto-optics, spintronic devices, and ultrafast optics. He has authored more than 400 publications, several book chapters, and co-edited the CRC Handbook of Optofluidics. He is a Fellow of the National Academy of Inventors, the IEEE and the Optical Society of America. He received an NSF Career Award, a Keck Futures Nanotechnology Award, and the Engineering Achievement Award by the IEEE Photonics Society.
Min-Gon Kim, Professor at GIST (Gwangju Institute of Science and Technology), CEO of GMDBiotech
Min-Gon Kim Biographical Sketch
Dr. Min-Gon Kim is a Professor at GIST and the CEO of GMDBiotech. He received his Ph.D. in Chemical Engineering from POSTECH. Specializing in biosensors and Lab-on-Paper platforms, he has established a prolific academic record with over 150 publications and 40 patents. Currently, he is leading the development and commercialization of high-sensitivity POCT and digital diagnostic systems.
Nancy Allbritton, Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington
Nancy Allbritton Biographical Sketch
Nancy L. Allbritton is the Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering at the University of Washington in Seattle.
Her research focuses on the development of novel technologies for applications in single-cell analysis, micro-arrays and fluidics, and organ-on-chip and has resulted in over 180 full-length journal publications and patents and led to 15 commercial products. Her research program has been well funded by the National Institutes of Health with $60 million in grant funding since 1994. Four companies have been formed based on her research discoveries: Protein Simple (acquired by Bio-Techne in 2014 for $308M), Intellego (subsequently integrated into International Rectifier), Cell Microsystems (www.cellmicrosystems.com), and Altis Biosystems (www.altisbiosystems.com). Dr. Allbritton is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical & Biological Engineering, and the National Academy of Inventors. She obtained her B.S. in physics from Louisiana State University, M.D. from Johns Hopkins University, and Ph.D. in Medical Physics/Medical Engineering from the Massachusetts Institute of Technology, with a postdoctoral fellowship at Stanford University.
Noah Malmstadt, Professor, Mork Family Dept. of Chemical Engineering & Materials Science, University of Southern California
Noah Malmstadt Biographical Sketch
Noah Malmstadt is Professor at the University of Southern California. He received a BS in Chemical Engineering from Caltech and a PhD in Bioengineering from the University of Washington. Following postdoctoral work at UCLA, he joined the Mork Family Department of Chemical Engineering and Materials Science at USC in 2007. Malmstadt is the recipient of a 2012 Office of Naval Research Young Investigator award. His research focuses on microfluidic strategies to facilitate material fabrication and biophysical analysis. He has pioneered the integration of ionic liquids as solvents in droplet microreactors and the application of microfluidic systems to synthesizing biomimetic cell membranes. Microfluidic analytical techniques he has developed include methods for measuring the permeability of cell membranes to druglike molecules and techniques for measuring ionic currents through membrane proteins.
Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering
Roman Voronov Biographical Sketch
Roman S. Voronov is a tenured Associate Professor of Chemical and Material’s Engineering at the New Jersey Institute of Technology (NJIT), since September 2013. He also holds a joint appointment in Biomedical Engineering since 2020. Additionally, Prof. Voronov is the founder and president of an STTR-funded startup company AltVIVO, Inc. that specializes in producing advanced cell culturing equipment. His laboratory has two main research directions: computer-driven tissue engineering, and blood systems biology. Prof. Voronov’s work in these areas has been funded by NIH, NSF and private ventures. Prior to his appointment at NJIT, Prof. Voronov was an American Heart Association Postdoctoral Fellow in the Department of Chemical & Biomolecular Engineering at the University of Pennsylvania. Prior to that, Dr. Voronov held a brief post-doctoral appointment at the University of Oklahoma (OU) studying enhanced oil recovery from porous rock formations as a part of Advanced Energy Consortium. He received his PhD in 2010, MS in 2006, and BS (Summa Cum Laude with a Minor in Physics) in 2003 in Chemical Engineering from OU.
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas
Steve Soper Biographical Sketch
Professor Soper (since 2016) is a Foundation Distinguished Professor in Chemistry and Mechanical Engineering at the University of Kansas. At KUMC, Prof. Soper holds an adjunct appointment in the Cancer Biology Department and is a member of the KU Cancer Center. He also holds an appointment at Ulsan National Institute of Science and Technology in Ulsan, South Korea, where he is a World Class University Professor.
As a result of his efforts, Prof. Soper has secured extramural funding totaling >$125M, has published over 245 peer-reviewed manuscripts (h index = 70; >17,000 citations); 31 book chapters and 71 peer-reviewed conference proceeding papers, and is the author of 12 patents. He is also the founder of a startup company, BioFluidica, which is marketing devices for the isolation and enumeration of liquid biopsy markers. Soper recently founded a second company, Sunflower Genomics, which is seeking to market a new DNA/RNA single-molecule sequencing platform. His list of awards includes Ralph Adams Award in Bioanalytical Chemistry, Chemical Instrumentation by the American Chemical Society, the Benedetti-Pichler Award for Microchemistry, Fellow of the AAAS, Fellow of Applied Spectroscopy, Fellow of the Royal Society of Chemistry, R&D 100 Award, Distinguished Masters Award at LSU and Outstanding Scientist/Engineer in the state of Louisiana in 2001. Finally, Prof. Soper has granted 50 PhDs and 7 MS degrees to students under his mentorship. He currently heads a group of 15 researchers.
His major discoveries include: (1) Technology for the detection of liquid biopsy markers that can manage a variety of diseases using a simple blood test (test has been demonstrated in multiple myeloma, pediatric acute lymphoblastic leukemia, acute myeloid leukemia, pancreatic, breast, colorectal, prostate, and ovarian cancers); (2) new hardware and assay for the point-of-care diagnosis of acute ischemic stroke; (3) single-molecule DNA and RNA sequencing nanotechnology; and (4) currently working on a home-test for COVID-19 infections (handheld instrument and the associated assay.
Xing Wang, Associate Professor, Holonyak Micro and Nanotechnology Laboratory (HMNTL) Cancer Center at Illinois (CCIL), University of Illinois at Urbana-Champaign (UIUC)
Xing Wang Biographical Sketch
Dr. Xing Wang is an Associate Professor in the Department of Bioengineering, affiliated with the Chemistry Department, IGB, HMNTL, and CCIL at UIUC. He received a Ph.D. in Chemistry from New York University and did postdoc training at Princeton University focusing on RNA biochemistry/biology and noncoding RNA-mediated genome editing. His group invented the DNA Star, DNA Net, and DNA NanoGripper platforms, and conceived the concept of pattern-recognition enabled multivalent molecular interactions. Dr. Wang received the Mikashi Award in 2021, was selected as a Fellow of the Y Combinator Founder Cohort that same year, and earned the Spoke Award in 2024. His research group utilizes nucleic acid and protein engineering to evolve new molecular binders for important and emerging biomarkers, and to design and customize DNA nanostructure-based “plug-and-play” platforms for bioengineering and biomedical applications. Dr. Wang’s research group is mainly supported by the National Institutes of Health (NIH) and National Science Foundation (NSF).
08:00
27 October 2026
Conference Entrance
Participants Check-In
Conference Registration, Materials Pick-Up, Continental Breakfast and Networking
09:00
27 October 2026
Crystal Ballroom I
Plenary Presentation
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, United States of America
Presentation Title to be Confirmed
09:30
27 October 2026
Crystal Ballroom I
Plenary Presentation
Nancy Allbritton, Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington, United States of America
Presentation Title to be Confirmed
10:00
27 October 2026
Crystal Ballroom I
Plenary Presentation
Gregory Nordin, Professor, Brigham Young University, United States of America
Presentation Title to be Confirmed
10:30
27 October 2026
Exhibit Hall
Mid-Morning Coffee Break and Networking in the Exhibit Hall -- Meet Exhibitors and Network with Colleagues
11:15
27 October 2026
Crystal Ballroom I
Plenary Presentation
Abraham Lee, Professor, Biomedical & Mechanical Engineering, Pharmaceutical Science, Ctr for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine, United States of America
Microfluidics for Immunoengineering and Immunotherapy
Precision medicine is the paradigm to develop treatments for patients based on molecular-targets that are effective in vivo when administered. That is, one must not only be able to identify molecular and cellular targets that are the source of disease but also understand how these targets behave inside the body based on physiological principles. Recent developments in microfluidics have contributed to burgeoning precision medicine fields such as liquid biopsy, immunotherapy, single cell analysis, molecular , and microphysiological systems. Since microfluidics bridges the scales of molecular, cellular, tissue, and can even recapitulate organ and circulatory functions of the body it is the ideal platform technology to develop personalized medicine. Adoptive cell therapy (ACT) involves the processing of blood from a donor to isolate cells (e.g. T cells) for genetic manipulation followed by reinfusion back into patients. Specifically for CAR T cell therapy, genetic coding material (e.g. DNA, mRNA) is inserted into the T cells to express chimeric antigen receptors to target biomarkers of cancer cells and trigger an activated immune response towards the tumor of interest. This process that starts from blood drawn from one person and ends with specialized engineered cells delivered to the patient includes multiple tedious and costly steps, and can require a long time that the patient may not have. In this talk I will introduce three microfluidic platforms developed in my lab and applied to the process of cellular engineering and immunotherapy. First, a lateral cavity acoustic transducer (LCAT) was used for processing blood samples, isolating immune cells, transfecting cells, and finally expanding T cells to scale up for treatment. We developed the acoustic electric shear orbiting poration (AESOP) device to uniformly deliver genetic cargos into a large population of cells simultaneously for high quality transfected cells with controlled dosage delivery of different genetic cargos. Second, we constructed bottom-up artificial antigen presenting cells (aAPCs) for antigen-specific T cell activation based on droplet microfluidics. Finally, I will introduce a new droplet-based platform that is capable of studying the 3D cell morphology of both the cell surface and also its intracellular constituents to further understand immune cell activation status.
11:45
27 October 2026
Crystal Ballroom I
Greg Cooksey, Project Leader, Microsystems and Nanotechnology Division, National Institute of Standards and Technology (NIST)
Presentation Title to be Confirmed
12:15
27 October 2026
Crystal Ballroom I
Claudia Gärtner, CEO, microfluidic ChipShop GmbH, Germany
Presentation Title to be Confirmed
13:00
27 October 2026
Exhibit Hall
Networking Buffet Lunch -- Meet Exhibitors and Engage
13:59
27 October 2026
Crystal Ballroom I
Session: Point-of-Care and Rapid Diagnostics -- Chaired by Professor Brian Cunningham
14:00
27 October 2026
Crystal Ballroom I
Keynote Presentation
Brian Cunningham, Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign, United States of America
Presentation Title to be Confirmed
14:30
27 October 2026
Crystal Ballroom I
Abraham Qavi, Assistant Professor, Director of Point of Care Testing, Director of Innovative Laboratory Diagnostics, University of California-Irvine, United States of America
Engineering Light for Rapid Point-of-Care Diagnostics
Rapid, accurate point-of-care diagnostics are increasingly critical for timely clinical decision-making, particularly in settings where reliance on centralized laboratory testing introduces delays that prolong clinical decision points and adversely impact patient care. In this talk, I will discuss how photonic resonators and plasmonic-enhanced sensing strategies can be integrated into compact, scalable diagnostic formats suitable for point-of-care testing. Emphasis will be placed on rapid detection of viral targets and the associated host response. The presentation will also address practical considerations for point-of-care deployment, including assay robustness, regulatory pathways, and integration with existing clinical workflows. Together, these examples illustrate how advanced optical biosensing technologies can move beyond proof-of-concept toward clinically impactful diagnostics.
15:00
27 October 2026
Crystal Ballroom I
Min-Gon Kim, Professor at GIST (Gwangju Institute of Science and Technology), CEO of GMDBiotech, Republic of Korea
High-Sensitivity and Multiplex POCT Sensors Based on Lab-on-Paper Technology
We present advanced lab-on-paper platforms for high-sensitivity POCT. First, we demonstrate an ultrasensitive Metal-Enhanced Fluorescence (MEF) LFA for Influenza A, achieving PCR-level accuracy. Additionally, we introduce a multiplexed ovarian cancer diagnostic utilizing laser-patterned membranes to simultaneously profile five exosomal biomarkers without concentration. These results highlight our platforms' potential for next-generation precision diagnostics.
15:30
27 October 2026
Crystal Ballroom I
Xing Wang, Associate Professor, Holonyak Micro and Nanotechnology Laboratory (HMNTL) Cancer Center at Illinois (CCIL), University of Illinois at Urbana-Champaign (UIUC), United States of America
Designer DNA Architectures for Disease Diagnosis
Biological entities such as viruses and cells present distinct spatial patterns of surface proteins. Such protein marker features can be selectively recognized by various binders, including aptamers, nanobodies, and antibodies. We have created a suite of designer DNA nanostructures (DDNs), including the DNA Star, DNA Net, DNA NanoGripper, that present multiple protein-targeting binders in two-dimensional (2D) or three-dimensional (3D) configurations. These architectures offer pattern recognition-enabled multivalent interactions, resulting in significantly enhanced binding avidity and selectivity toward target viruses or cells. Using this strategy, we design highly effective molecular probes and targeted delivery platforms for achieving advanced biosensors and therapeutic candidates.
In this talk, I will introduce the principle of pattern recognition-enabled multivalent interactions that my group has proposed and established. I will then highlight our recent efforts in (1) developing DNA Net-enabled lateral flow assay biosensing platforms for rapid, low-cost, ultrasensitive detection of human and animal virus infections in at-home-, self-, or on-farm test settings; and (2) designing and synthesizing a human hand-like DNA nanorobot (called NanoGripper) for the recognition and capture of nanometer scale objects, including virus particles.
16:00
27 October 2026
Exhibit Hall
Coffee Break and Networking with the Exhibitors
16:30
27 October 2026
Crystal Ballroom I
Roman Voronov, Associate Professor, Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology Newark College of Engineering, United States of America
Presentation Title to be Confirmed
17:00
27 October 2026
Crystal Ballroom I
Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz, United States of America
Presentation Title to be Confirmed